Physician profile
John W Prather
NPI 1043233372
$2,403.08
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,530 · 2020: $873.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $471.97 | 2019 | |
| Abbott Laboratories | $399.94 | 2019-2020 | |
| Boston Scientific Corporation | $348.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $259.68 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $227.84 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $116.38 | 2019-2020 | |
| Pfizer INC. | $97.65 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $90.98 | 2019-2020 | |
| Astellas Pharma US INC | $74.99 | 2019 | |
| Abiomed | $65.86 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $61.36 | 2019 | |
| Chiesi USA, INC. | $34.78 | 2019-2020 | |
| Amgen INC. | $27.01 | 2019 | |
| Cardiva Medical, INC. | $23.53 | 2019 | |
| Amarin Pharma, INC. | $22.89 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $18.94 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.96 | 2019 | |
| Elutia, INC. | $16.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Prather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.